Ipsen: Information Relating to the Holding of the Combined Shareholders’ Meeting of 24 May 2022
The Shareholders of Ipsen are invited to the Combined Shareholders’ Meeting on 24 May 2022 at 3:00 p.m. in Paris. Important resolutions include the approval of a €1.20 dividend per share for FY2021, with an ex-date of 31 May 2022 and payment on 2 June 2022. The meeting's preliminary notice was published on 15 April 2022, and final details will be available on Ipsen's website. The company remains focused on transformative medicines across Oncology, Rare Disease, and Neuroscience with €2.6bn in Specialty Care sales for FY2021.
- Approval of a €1.20 dividend per share for FY2021.
- Strong Specialty Care sales of €2.6bn in FY2021.
- None.
FORMALITIES FOR MAKING AVAILABLE AND CONSULTING PREPARATORY DOCUMENTS TO THE MEETING
The Shareholders of the Company are invited to participate in the Combined Shareholders’ Meeting of Ipsen (Euronext: IPN; ADR: IPSEY) to be held on Tuesday,
The preliminary notice of the Meeting (“avis de réunion”) was published in the Bulletin des Annonces Légales Obligatoires (BALO) of
The Shareholders will be asked to approve in particular the following resolutions:
-
The payment of a dividend of
€1.20 per share for the financial year 2021, the ex-date being set on31 May 2022 and the dividend payment on2 June 2022 ;
-
The renewal of the terms of office of Highrock S.àr.l., Mr.
Paul SEKHRI and Mr.Piet WIGERINCK as Directors for a term of 4 years, as well as the ratification of the temporary appointment of Mrs.Karen WITTS as a Director, maintaining the independence Directors’ rate within the Board of Directors at a third in accordance with the Afep-Medef Code and each gender’s proportion at more than40% in accordance with the law (the Director representing the employees being not taken into account in these rates).
In accordance with applicable regulatory provisions:
- Registered shareholders may, up to the fifth day (inclusive) before the Meeting, request from the Company to send these documents, where appropriate at his/her express request by electronic means. For holders of bearer shares, the exercise of this right is subject to the presentation of a shareholding certificate (attestation de participation) in the bearer securities accounts managed by the authorized intermediary.
- Any shareholder may consult these documents at the Company’s headquarters.
In the context of the Covid-19 pandemic, the Company may have to modify the procedures for holding and/or participating in the Shareholders' Meeting of
Ipsen
Ipsen is a global, mid-sized biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease and Neuroscience. With Specialty Care sales of
View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005669/en/
Ipsen
Source: Ipsen
FAQ
What is the date and time of the Ipsen shareholders’ meeting?
What dividend will Ipsen shareowners receive for FY2021?
When will the dividend be paid to Ipsen shareholders?
Where can I find information about Ipsen’s shareholders’ meeting?